[1]
Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY. Incidence, mortality, and racial differences in peripartum cardiomyopathy. The American journal of cardiology. 2007 Jul 15:100(2):302-4
[PubMed PMID: 17631087]
[2]
Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. International journal of cardiology. 2009 Jan 9:131(2):168-79. doi: 10.1016/j.ijcard.2008.06.054. Epub 2008 Aug 22
[PubMed PMID: 18722678]
Level 1 (high-level) evidence
[3]
Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. Journal of the American Heart Association. 2014 Jun 4:3(3):e001056. doi: 10.1161/JAHA.114.001056. Epub 2014 Jun 4
[PubMed PMID: 24901108]
[4]
Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethnicity & disease. 2007 Spring:17(2):228-33
[PubMed PMID: 17682350]
[5]
Hasan JA, Qureshi A, Ramejo BB, Kamran A. Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital. JPMA. The Journal of the Pakistan Medical Association. 2010 May:60(5):377-80
[PubMed PMID: 20527612]
[6]
Pandit V, Shetty S, Kumar A, Sagir A. Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Tropical doctor. 2009 Jul:39(3):168-9. doi: 10.1258/td.2008.080353. Epub
[PubMed PMID: 19535757]
[7]
Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH. Frequency of peripartum cardiomyopathy. The American journal of cardiology. 2006 Jun 15:97(12):1765-8
[PubMed PMID: 16765131]
[8]
Farber PA, Glasgow LA. Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. American heart journal. 1970 Jul:80(1):96-102
[PubMed PMID: 4316715]
[9]
Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B, Arif G, Essop R, Ansari A, Fett J, Yacoub M. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. American heart journal. 2005 Aug:150(2):263-9
[PubMed PMID: 16086928]
[10]
Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. American journal of obstetrics and gynecology. 1997 Jan:176(1 Pt 1):189-95
[PubMed PMID: 9024112]
[11]
Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN. A mechanistic role for cardiac myocyte apoptosis in heart failure. The Journal of clinical investigation. 2003 May:111(10):1497-504
[PubMed PMID: 12750399]
[12]
Drexler H. Changes in the peripheral circulation in heart failure. Current opinion in cardiology. 1995 May:10(3):268-73
[PubMed PMID: 7612976]
Level 3 (low-level) evidence
[13]
Cénac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. International journal of cardiology. 1992 Jul:36(1):57-9
[PubMed PMID: 1428253]
Level 2 (mid-level) evidence
[14]
Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005 Dec 6:112(23):3577-83
[PubMed PMID: 16330699]
[15]
Hopp L, Haider B, Iffy L. Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. International journal of cardiology. 1996 Dec 13:57(3):227-32
[PubMed PMID: 9024910]
[17]
Koide T, Saito Y, Sakamoto T, Murao S. Peripartal cardiomyopathy in Japan. A critical reappraisal of the concept. Japanese heart journal. 1972 Nov:13(6):488-501
[PubMed PMID: 4539938]
[18]
Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. American journal of obstetrics and gynecology. 2005 Aug:193(2):363-5
[PubMed PMID: 16098856]
[20]
Bassett JM, Burks AH, Levine DH, Pinches RA, Visser GH. Maternal and fetal metabolic effects of prolonged ritodrine infusion. Obstetrics and gynecology. 1985 Dec:66(6):755-61
[PubMed PMID: 3934609]
[21]
Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstetrics and gynecology. 1999 Aug:94(2):311-6
[PubMed PMID: 10432149]
[22]
Khan A, Paré E, Shah S. Peripartum Cardiomyopathy: a Review for the Clinician. Current treatment options in cardiovascular medicine. 2018 Sep 29:20(11):91. doi: 10.1007/s11936-018-0690-3. Epub 2018 Sep 29
[PubMed PMID: 30269217]
[23]
Ma GG, Fang Q, Wang FX. The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies. Cardiology journal. 2019:26(6):744-752. doi: 10.5603/CJ.a2018.0074. Epub 2018 Jul 16
[PubMed PMID: 30009373]
Level 1 (high-level) evidence
[24]
Gaddipati VC,Patel AA,Cohen AJ, The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy. Case reports in cardiology. 2017
[PubMed PMID: 28890834]
Level 3 (low-level) evidence
[25]
Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010 Apr 6:121(13):1465-73. doi: 10.1161/CIRCULATIONAHA.109.901496. Epub 2010 Mar 22
[PubMed PMID: 20308616]
Level 3 (low-level) evidence
[26]
Mouquet F, Mostefa Kara M, Lamblin N, Coulon C, Langlois S, Marquie C, de Groote P. Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: impact of cardiac resynchronization therapy. European journal of heart failure. 2012 May:14(5):526-9. doi: 10.1093/eurjhf/hfs031. Epub 2012 Mar 23
[PubMed PMID: 22447949]
[27]
Yaméogo NV, Samadoulougou AK, Kagambèga LJ, Kologo KJ, Millogo GRC, Thiam A, Guenancia C, Zansonré P. Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy. BMC cardiovascular disorders. 2018 Jun 18:18(1):119. doi: 10.1186/s12872-018-0856-7. Epub 2018 Jun 18
[PubMed PMID: 29914408]
[28]
Dayoub EJ,Datwani H,Lewey J,Groeneveld PW, One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy. Journal of cardiac failure. 2018 Oct
[PubMed PMID: 30194024]
[29]
Honigberg MC, Sarma AA. Pregnancy Among Survivors of Childhood Cancer: Cardiovascular Considerations. Current treatment options in cardiovascular medicine. 2018 Jun 19:20(7):54. doi: 10.1007/s11936-018-0650-y. Epub 2018 Jun 19
[PubMed PMID: 29923132]